<DOC>
	<DOCNO>NCT02253914</DOCNO>
	<brief_summary>Study determine safety , tolerability pharmacokinetics BILR 355 BS plus low dose ritonavir healthy male volunteer .</brief_summary>
	<brief_title>Dose Escalation Study Safety , Tolerability Pharmacokinetics BILR 355 BS Plus Low Dose Ritonavir HIV-uninfected Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<criteria>1 . Males meet follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test No find deviate normal ( except note ) clinical relevance No evidence clinically relevant concomitant disease 2 . Age ≥18 year &lt; 60 3 . BMI ≥18.5 BMI ≤29.9 kg/m2 ( Body Mass Index ) 4 . Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation 1 . Current medically relevant gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Surgery gastrointestinal tract ( except appendectomy ) 3 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 4 . History relevant orthostatic hypotension , faint spell blackouts 5 . Chronic relevant acute infection 6 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 7 . Intake drug long halflife ( &gt; 24 hour ) within one month prior administration study drug trial 8 . Use drug within 10 day prior administration trial , might reasonably influence result trial base knowledge time protocol preparation 9 . Participation another trial investigational drug within one month prior administration trial 10 . Smoker 11 . Inability refrain smoke trial day 12 . Alcohol abuse ( 60 g/day ) 13 . Drug abuse 14 . Recent blood donation ( 100 mL within 4 week prior administration trial ) 15 . Excessive physical activity ( within 1 week prior administration trial ) 16 . Any laboratory value outside normal reference range clinical relevance 17 . Inability comply dietary regimen study centre 18 . Infected hepatitis B hepatitis C virus ( define either hepatitis B surface antigen , hepatitis B core antibody , hepatitis C antibody positive ) 19 . HIV1 infect define positive HIV ELISA test</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>